CVS Health (NYSE:CVS) Lowered to “Market Perform” at Leerink Partnrs

CVS Health (NYSE:CVS – Get Free Report) was downgraded by stock analysts at Leerink Partnrs from an “outperform” rating to a “market perform” rating in a note issued to investors on Wednesday, Zacks.com reports. Leerink Partnrs also issued estimates for CVS Health’s Q4 2024 earnings at $1.94 EPS and FY2027 earnings at $9.68 EPS. A […]

Leave a Reply

Your email address will not be published.

Previous post Choreo LLC Acquires New Holdings in Invesco S&P 500 Equal Weight Technology ETF (NYSEARCA:RSPT)
Next post Kestra Private Wealth Services LLC Grows Stock Position in Devon Energy Co. (NYSE:DVN)